Powering Booster Production
Serum Extracted from bovine fetuses in slaughterhouses to a platform for naturally programmable extracellular signaling
Streamlined Three-Step Booster Production
Get Cells
We source high-quality cells from established cell banks, off-the-shelf vials, or other qualified repositories.
Sourcing healthy, standardized off-the-shelf source cells from cell banks ensures a robust and compliant biological starting material for Booster production.
Extracellular Vesicles (EVs)
Cells communicate and regulate biological responses through different mechanisms. EVs are an example. Membrane-bound particles released by cells carry proteins, RNA, lipids, and other signaling cargo.
Nano-to-Micron
EVs exhibit a heterogenous size distribution from the nanoscale to the sub-micron scale
2013
Nobel Prize for their discoveries of the molecular machinery that regulates vesicle traffic – the cell's vital transport system (James E. Rothman, Randy W. Schekman, and Thomas C. Südhof)
Scientific Rationale & Mechanistic Basis
Electromagnetic field technology induces mitohormesis (mitochondrial survival adaptations). This promotes mitochondriogenesis and reduces apoptosis.
Magnetic modulation activates a TRPC1-mediated calcium–mitochondrial signalling axis, enhancing cellular respiration and upregulating PGC-1α expression. This metabolic reprogramming supports the production of an enriched secretome containing key proteins and bioactive molecules.
Tested Across Diverse Cell Types
HEK Cells
Mesenchymal Stem Cells (MSCs)
C2C12 Cells
Fibroblasts
Fish Cells
Cultivated Meat Cells
Booster vs FBS — Cell Growth Results
Head-to-head performance across HEK293T cells shows nearly 2× higher cell density with Booster compared to FBS at equivalent concentrations.
HEK293T
Booster-treated HEK293T cells reach nearly double the density of FBS-treated cultures under identical conditions.
Fully xeno-free formulation with no fetal bovine serum, no animal-derived additives, and no batch variability.
Data generated in-house under standardised culture conditions. Results are representative of ≥3 independent replicates.
Competitive Technical Landscape
| Parameter | FBS (Fetal Bovine Serum) | Recombinant Proteins | Hydrolysates | HPL (Platelet Lysate) | Cellivate BOOSTER |
|---|---|---|---|---|---|
| Performance | High (Broad) | Moderate–High (Narrow) | Moderate | High (Specific) | High (Targeted & Broad) |
| Scalability | Limited (Slaughterhouse) | Limited (Cost-driven) | High | Limited | High (Cell-based loop) |
| Complexity | High (Undefined) | Low | Moderate | High | High (Functional Signaling) |
| Cost Trajectory | Increasing (Supply constraints) | High | Low–Moderate | High | Decreasing with scale |